CD37 and acute myeloid leukemia: It is primarily expressed in immune cells,including T cells and B cells, and is involved in immune cell signaling.EVs carrying CD37 can serve as prognostic biomarkers, and potentiallyas therapeutic targets, for acute myeloid leukemia (AML).